Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome-Reference-Cited by-同舟云学术

Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome

Published:2021-09-12 Issue:11 Volume:23 Page:2879-2893
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorectal Dis

Author:

Murray Nigel P.¹²^ORCID,Villalon Ricardo³^ORCID,Hartmann Dan²^ORCID,Rodriguez Maria Patricia¹^ORCID,Aedo Socrates²^ORCID

Affiliation:

1. Servicio de Medicina Hospital de Carabineros de Chile Santiago Chile

2. Facultad de Medicina Universidad Finis Terrae Santiago Chile

3. Servicio de Coloproctologia Hospital de Carabineros de Chile Santiago Chile

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/codi.15899

Reference45 articles.

1. Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association

2. Comparison of the guidelines for colorectal cancer in Japan, the USA and Europe

3. Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells

4. Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer

5. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of minimal residual disease and treatment;Advances in Clinical Chemistry;2024

2. Comparison of NOD-like and Toll-like receptors gene expression levels in blood monocytes of colon cancer patients;Cellular and Molecular Biology;2023-12-31

3. Is Laparoscopic Complete Mesocolic Excision and Central Vascular Ligation Really Necessary for All Patients With Right-Sided Colon Cancer?;Annals of Coloproctology;2021-12-31